BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34704360)

  • 21. Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.
    Wang Q; Jiang Z; Qi X; Lu S; Wang S; Leng C; Lu F; Liu H; Liang S; Shi J
    Clin Transl Oncol; 2014 Nov; 16(11):1000-5. PubMed ID: 24894840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
    Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006121. PubMed ID: 28945270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis.
    Zheng MH; Sun HT; Xu JG; Yang G; Huo LM; Zhang P; Tian JH; Yang KH
    Biomed Res Int; 2016; 2016():5807346. PubMed ID: 27006948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
    Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006121. PubMed ID: 22972090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
    Mehta MP; Shapiro WR; Phan SC; Gervais R; Carrie C; Chabot P; Patchell RA; Glantz MJ; Recht L; Langer C; Sur RK; Roa WH; Mahe MA; Fortin A; Nieder C; Meyers CA; Smith JA; Miller RA; Renschler MF
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1069-76. PubMed ID: 18977094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial.
    Verger E; Gil M; Yaya R; Viñolas N; Villà S; Pujol T; Quintó L; Graus F
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):185-91. PubMed ID: 15629610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study.
    Giorgio CG; Giuffrida D; Pappalardo A; Russo A; Santini D; Salice P; Blanco G; Castorina S; Failla G; Bordonaro R
    Lung Cancer; 2005 Nov; 50(2):247-54. PubMed ID: 16039010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.
    Mulvenna P; Nankivell M; Barton R; Faivre-Finn C; Wilson P; McColl E; Moore B; Brisbane I; Ardron D; Holt T; Morgan S; Lee C; Waite K; Bayman N; Pugh C; Sydes B; Stephens R; Parmar MK; Langley RE
    Lancet; 2016 Oct; 388(10055):2004-2014. PubMed ID: 27604504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Liu ZL; Zhu WR; Zhou WC; Ying HF; Zheng L; Guo YB; Chen JX; Shen XH
    J Integr Med; 2014 Jul; 12(4):346-58. PubMed ID: 25074884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Temozolomide and Radiotherapy on Brain Metastatic Tumor: A Systematic Review and Meta-Analysis.
    Ma W; Li N; An Y; Zhou C; Bo C; Zhang G
    World Neurosurg; 2016 Aug; 92():197-205. PubMed ID: 27072333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole brain radiotherapy with concurrent temozolomide in multifocal and/or multicentric newly diagnosed glioblastoma.
    Lahmi L; Idbaih A; Rivin Del Campo E; Hoang-Xuan K; Mokhtari K; Sanson M; Canova CH; Carpentier A; Jacob J; Maingon P; Feuvret L
    J Clin Neurosci; 2019 Oct; 68():39-44. PubMed ID: 31399318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.
    Zhao Q; Qin Q; Sun J; Han D; Wang Z; Teng J; Li B
    PLoS One; 2016; 11(3):e0150419. PubMed ID: 26930609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation].
    Conill C; Fernández-Ibiza J; Malvehy J; Puig S; Sánchez M; Castel T
    Med Clin (Barc); 2004 Mar; 122(11):413-5. PubMed ID: 15066248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
    Tsao MN; Lloyd N; Wong RK; Chow E; Rakovitch E; Laperriere N; Xu W; Sahgal A
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003869. PubMed ID: 22513917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer.
    Doherty MK; Korpanty GJ; Tomasini P; Alizadeh M; Jao K; Labbé C; Mascaux CM; Martin P; Kamel-Reid S; Tsao MS; Pintilie M; Liu G; Bradbury PA; Feld R; Leighl NB; Chung C; Shepherd FA
    Radiother Oncol; 2017 May; 123(2):195-202. PubMed ID: 28363487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC.
    Ren Y; Wang SB; Zhou L; Liu SQ; Du LY; Li T; Jiang MQ; Lei KJ; Tan BX; Jia YM
    Technol Cancer Res Treat; 2021; 20():15330338211011968. PubMed ID: 33955301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer.
    Yang RF; Yu B; Zhang RQ; Wang XH; Li C; Wang P; Zhang Y; Han B; Gao XX; Zhang L; Jiang ZM
    Braz J Med Biol Res; 2017 Nov; 51(1):e6073. PubMed ID: 29185589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non-small cell lung cancer: A meta-analysis.
    Li Z; Liu Z; Wu Y; Li H; Sun Z; Han C; Zhang X; Zhang J
    Thorac Cancer; 2021 Nov; 12(21):2838-2848. PubMed ID: 34622571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.